Kemal Malik, M.D.
Dr. Kemal Malik has served on our board of directors since 1st January 2020. He is an experienced industry leader with a distinguished career in the pharmaceutical industry. He has been responsible for bringing many innovative medicines, in several therapeutic areas, through R&D to successful commercialization. From 2014 to 2019 he served as a member of the Board of Management of Bayer AG, responsible for Innovation across the Bayer group. Prior to this he was Head of Global Development and Chief Medical Officer in Bayer Healthcare for ten years. He was also responsible for the creation and leadership of Bayer LEAPS, the organizational unit responsible for strategic venturing in areas of disruptive breakthrough innovation.
Dr. Malik has a degree in Pharmacology from the University of London and qualified in Medicine at Imperial College School of Medicine, London. He is a Member of the Royal College of Physicians.